Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(ombitasvir paritaprevir ritonavir dasabuvir)
358 results
  • High efficacy of Resistance-guided retreatment of HCVpatients failing NS5A inhibitors in real world. [Journal Article]
    J Hepatol 2019Belén Pérez A, Chueca N, … GEHEP-004 Cohort
  • CONCLUSIONS: In our study we show how the resistance-guided retreatment in conjunction with an interpreted report allows achieving SVR rates close to 90%. We hypothesize that SVR rates may even be improved if resistance data are discussed between experienced virologists and treating clinicians. We believe that our data may be relevant for countries where the access to new DAA combination regimens is limited.
New Search Next